FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Valeant Pharmaceuticals North America Fenoglide Recall

Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Nov 11, 2015
Recall ID
D-0163-2016
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Fenoglide starting Sep 4, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0163-2016 on Nov 11, 2015. Reason: Failed Dissolution Specifications: Failed 24 month dissolution testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Failed 24 month dissolution testing.

Product description

Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.

Lot numbers, UPCs & expiration codes

Lot # 1300939, Expiry: March 2016.

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0163-2016
Classification
Class II
Status
Terminated
Recall initiated
Sep 4, 2015
FDA report date
Nov 11, 2015
Quantity
3341 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0163-2016, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
72214
Address
400 Somerset Corporate Blvd
Code information
Lot # 1300939, Expiry: March 2016.
Postal code
08807-2867
Report date
Nov 11, 2015
Product type
Drugs
Recall number
D-0163-2016
Classification
Class II
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
3341 Bottles
Termination date
Mar 14, 2017
Reason for recall
Failed Dissolution Specifications: Failed 24 month dissolution testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.
Distribution pattern
U.S. Nationwide
Recall initiation date
Sep 4, 2015
Initial firm notification
Letter
Center classification date
Nov 3, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0163-2016, published Nov 11, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls